SCHEDULE 13D/A 0001193125-23-067134 0001491072 XXXXXXXX LIVE 6 Ordinary Shares, NIS 5.00 par value 07/11/2025 false 0001643303 63008G203 Nano Dimension Ltd.

2 ILAN RAMON NESS ZIONA L3 7403635

Tony Moore 214-866-0202 Anson Funds Management LP 16000 Dallas Parkway, Suite 800 Dallas TX 75248 Ele Klein & Adriana Schwartz 212-756-2000 Schulte Roth & Zabel LLP 919 Third Avenue New York NY 10022 0001491072 N Anson Funds Management LP AF N TX 0.00 9057952.00 0.00 9057952.00 9057952.00 N 4.2 IA PN The 9,057,952 ordinary shares reported herein are represented by 9,057,952 ADSs. 0001491073 N Anson Management GP LLC AF N TX 0.00 9057952.00 0.00 9057952.00 9057952.00 N 4.2 HC OO The 9,057,952 ordinary shares reported herein are represented by 9,057,952 ADSs. 0002012586 N Tony Moore AF N X1 0.00 9057952.00 0.00 9057952.00 9057952.00 N 4.2 IN HC The 9,057,952 ordinary shares reported herein are represented by 9,057,952 ADSs. 0001581079 N Anson Advisors Inc. WC N A6 0.00 9057952.00 0.00 9057952.00 9057952.00 N 4.2 CO The 9,057,952 ordinary shares reported herein are represented by 9,057,952 ADSs. 0001962354 N Amin Nathoo AF N Z4 0.00 9057952.00 0.00 9057952.00 9057952.00 N 4.2 IN HC The 9,057,952 ordinary shares reported herein are represented by 9,057,952 ADSs. 0001585167 N Moez Kassam AF N Z4 0.00 9057952.00 0.00 9057952.00 9057952.00 N 4.2 IN HC The 9,057,952 ordinary shares reported herein are represented by 9,057,952 ADSs. Ordinary Shares, NIS 5.00 par value Nano Dimension Ltd. 2 ILAN RAMON NESS ZIONA L3 7403635 This Amendment No. 6 ("Amendment No. 6") amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission on March 10, 2023 (as amended from time to time, the "Schedule 13D"). This Amendment No. 6 amends and restates Items 3 and 5(a)-(c), and (e) and supplements Item 6 as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 6 have the meanings set forth in the Schedule 13D. This Amendment No. 6 is the final amendment to the Schedule 13D and constitutes an "exit filing" for the Reporting Persons. The ADSs representing the Ordinary Shares reported herein as being beneficially owned by the Reporting Persons were purchased using working capital of the Funds. An aggregate of approximately $24,869,497.71 (excluding brokerage commissions) was used to purchase ADSs representing Ordinary Shares reported as beneficially owned by the Reporting Persons in this Schedule 13D. Such securities were acquired through open market purchases. See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Ordinary Shares and percentages of the Ordinary Shares beneficially owned by each of the Reporting Persons. The percentages used in this Schedule 13D are calculated based upon 217,283,476 shares outstanding as of April 30, 2025, as reported in Issuer's Report of Foreign Private Issuer on Form 20-F filed with the Securities and Exchange Commission on May 12, 2025. See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. The transactions by the Reporting Persons in the ADSs of the Issuer since the filing of Amendment No. 5, which were all in the open market, are set forth in Schedule A. In addition, on July 11, 2025. July 11, 2025 The Funds no longer hold the Derivative Agreements previously reported in Amendment No. 5 of the Schedule 13D. Anson Funds Management LP /s/ Tony Moore 07/14/2025 Anson Management GP LLC /s/ Tony Moore 07/14/2025 Tony Moore /s/ Tony Moore 07/14/2025 Anson Advisors Inc. /s/ Amin Nathoo and Moez Kassam 07/14/2025 Amin Nathoo /s/ Amin Nathoo 07/14/2025 Moez Kassam /s/ Moez Kassam 07/14/2025